department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

ARVINAS, INC. ($ARVN) · pharmadog

PUBLIC COMPANY

$ARVNARVINAS, INC.

New Haven, CT, USupdated 3h ago

SEC EDGAR ↗Yahoo Finance ↗

community read0 votes

pipeline

3

marketed

0

phase 3

0

catalysts ytd

2

approvals ytd

0

recalls ytd

0

Pipeline(3)

pipeline depth3 products

1Phase 11Phase 21pre_registration

Colorectal Cancer

Diffuse Large B-Cell Lymphoma

pre_registration

Human Epidermal Growth Factor Receptor 2 Negative Breast…

Upcoming

no upcoming catalysts on record

Recent(90d)

earnings (1) · phase 1 2 completion (1)

ARVINAS, INC. earnings

phase 1 2 completion

Arvinas Inc — samuraciclib (Phase I/II Trial Completion)

view all catalysts →

🐶 Hiring Signal

5 open roles at ARVINAS, INC. →

Where ARVINAS, INC. is staffing up — a leading indicator of pipeline and commercial priorities.

therapeutic areaOncology 3 CNS / Neuroscience 2

departmentR&D / Discovery 4 Medical Affairs 1

News

no news has mentioned this company yet

identifiers

ticker

$ARVN

SEC CIK

0001655759

country

US

source

sec_tickers

top tags

Oncology3 Colorectal Cancer1 DLBCL1 NSCLC1

mentioned in

0news items

entity-linker matched

$ARVN8.39000.00%

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

last refreshed 50m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

Active trials

phase2A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutationrecruitingn=159
phase1A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.recruitingn=255
phase2A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgerycompletedn=152
phase2Trial of ARV-110 in Patients With Metastatic Castration Resistant Prostate Cancercompletedn=248

$ARVN8.39000.00%

$ARVN8.39000.00%

Insider activity

source: SEC Form 4

open-market buys + sells

Mar 18, 26SELLBerkowitz Noah· Chief Medical Officer6,435 sh @ $11.10−$71K↗
Mar 6, 26BUYMorrison Briggs· director20,000 sh @ $13.40$268K↗
Feb 27, 26SELLHouston John G· director18,822 sh @ $13.24−$249K↗
Feb 27, 26SELLHouston John G· director11,787 sh @ $13.14−$155K↗
Feb 27, 26SELLHouston John G· director4,688 sh @ $13.24−$62K↗
Feb 23, 26SELLTeel Randy· President and CEO3,748 sh @ $12.16−$46K↗
Feb 23, 26SELLCacace Angela M· Chief Scientific Officer2,571 sh @ $12.16−$31K↗
Feb 23, 26SELLLoomis David K· Chief Accounting Officer1,108 sh @ $12.16−$13K↗
Feb 23, 26SELLCacace Angela M· Chief Scientific Officer1,038 sh @ $12.16−$13K↗
Feb 23, 26SELLTeel Randy· President and CEO1,038 sh @ $12.16−$13K↗
Feb 13, 26SELLBerkowitz Noah· Chief Medical Officer5,685 sh @ $11.89−$68K↗
Feb 13, 26SELLSaik Andrew· Chief Financial Officer5,134 sh @ $11.89−$61K↗
Feb 13, 26SELLCacace Angela M· Chief Scientific Officer4,592 sh @ $11.89−$55K↗
Feb 13, 26SELLTeel Randy· President and CEO4,403 sh @ $11.89−$52K↗
Feb 13, 26SELLLoomis David K· Chief Accounting Officer1,016 sh @ $11.89−$12K↗

routine RSU / option mechanics (5)

Feb 26, 26grantTeel Randy · President and CEO218,691 sh
Feb 26, 26grantTeel Randy · President and CEO147,791 sh
Feb 26, 26grantSaik Andrew · Chief Financial Officer67,000 sh
Feb 26, 26grantSaik Andrew · Chief Financial Officer45,000 sh
Feb 26, 26grantBerkowitz Noah · Chief Medical Officer67,000 sh